Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 1523: Cardiogenic Shock in the Setting AMI With VF/VT Arrest Necessitating Escalating MCS

Presenter: Andrew Corrigan

October 30, 2024

Presentation TCT 2024

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

Presenter: Jacob Moeller

October 29, 2024

Presentation TCT 2024

TCT 469: A Prospective Registry of Complications Associated With Temporary Mechanical Circulatory Support (The PROCTOR MCS Registry)

Presenter: Raef Fadel

October 28, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

Intrapericardial Mechanical Circulatory Support (MCS) System for Cardiogenic Shock (Percassist)

Presenter: Gerardo Noriega

October 28, 2024

Presentation TCT 2024

My Perspective on MCS - Progress Achieved and Opportunities for Improvement

Presenter: David Baran

October 27, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

Presentation Interventional Complications 2024

How to Safely Remove Large Bore Devices: ECMO/Distal Perfusion Cannulae/Impella/MCS

Presenter: Jeremy Rier

August 02, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Continue MCS for Another 14 days

Presenter: Manreet Kanwar

March 04, 2024

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

Advertisement

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 1523: Cardiogenic Shock in the Setting AMI With VF/VT Arrest Necessitating Escalating MCS

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

TCT 469: A Prospective Registry of Complications Associated With Temporary Mechanical Circulatory Support (The PROCTOR MCS Registry)

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Intrapericardial Mechanical Circulatory Support (MCS) System for Cardiogenic Shock (Percassist)

My Perspective on MCS - Progress Achieved and Opportunities for Improvement

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

How to Safely Remove Large Bore Devices: ECMO/Distal Perfusion Cannulae/Impella/MCS

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Continue MCS for Another 14 days

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

March 2024 Dispatch for the CV Team

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content